|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||
|
||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sF7827778-5C3E-11EF-829D-EB2785CE164B&I=39IZM&T=&OP=Display&O=html&O1=15381491&O2=954927669269&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DEfficacy%2520of%2520chemotherapy%2520with%2520carboplatin-paclitaxel%2520plus%2520bevacizumab%2520for%2520previously%2520treated%2520patients%2520with%2520advanced%2520non-small%2520cell%2520carcinoma%26rft.au%3DIgawa%252C%2520Satoshi%26rft.au%3DMaki%252C%2520Sachiyo%26rft.au%3DNagashima%252C%2520Yujiro%26rft.au%3DOtani%252C%2520Sakiko%26rft.date%3D2012-12-01%26rft.externalDocID%3D23235169%26rft.genre%3Darticle%26rft.issn%3D0385-0684%26rft.issue%3D13%26rft.jtitle%3DGan%2520to%2520kagaku%2520ryoho%26rft.spage%3D2509%26rft.volume%3D39%26rft_id%3Dinfo%253Apmid%252F23235169%26rft_id%3Dinfo%253Apmid%252F23235169%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-REFWORKS_EXPORT_TOOL-getReference-object,5-NCBI_PUBMED_FREE-getCitedRecord-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.82121&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15381491-sF7827778-5C3E-11EF-829D-EB2785CE164B" timestamp="2024-08-17T04:18:18Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954927669269</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>[Efficacy of chemotherapy with carboplatin-paclitaxel plus bevacizumab for previously treated patients with advanced non-small cell carcinoma].</jnl:atitle>
<jnl:jtitle>癌と化学療法</jnl:jtitle>
<jnl:date>2012-12-00</jnl:date>
<jnl:spage>2509</jnl:spage>
<jnl:epage>2512</jnl:epage>
<jnl:coden>GTKRDX</jnl:coden>
<jnl:issn>0385-0684</jnl:issn>
<jnl:volume>39</jnl:volume>
<jnl:issue>13</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2187-2449</jnl:eissn>
<jnl:language>jpn</jnl:language>
<jnl:coden>GTKRDX</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:2ac1d98f05da0373ac2c4cb46dc653c3d30d8e50</ctx:identifier>
<ctx:identifier>urn:UUID:sF7827778-5C3E-11EF-829D-EB2785CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)